Image not available

Stasinou T et al, 2015: Re: Antiplatelet and Anticoagulative Medication During Shockwave Lithotripsy.

Stasinou T, Bourdoumis A, Masood J.
Royal Devon and Exeter NHS Foundation Trust , Exeter, United Kingdom.

Abstract

J Endourol. 2015 Feb 18. [Epub ahead of print] 

Rate this blog entry:
0
 

Comments 1

Hans-Göran Tiselius on Friday, 24 July 2015 07:27

This is a valuable comment emphasizing the need of collaboration with cardiologists in order to deal with the treatment of patients taking new generations of anti-platelet agents after coronary surgery or stenting.

That aspirin in doses of 75 mg no longer should be considered a risk factor for bleeding during major surgery and therefore can be continued is in my mind a dangerous advice for patients planned for SWL. It was in a patient who had not stopped aspirin that I noticed the first large subcapsular hematoma in a lithotripter with small and sharp focus.

This is a valuable comment emphasizing the need of collaboration with cardiologists in order to deal with the treatment of patients taking new generations of anti-platelet agents after coronary surgery or stenting. That aspirin in doses of 75 mg no longer should be considered a risk factor for bleeding during major surgery and therefore can be continued is in my mind a dangerous advice for patients planned for SWL. It was in a patient who had not stopped aspirin that I noticed the first large subcapsular hematoma in a lithotripter with small and sharp focus.
Guest
Friday, 28 July 2017
STORZ MEDICAL AG
Lohstampfestrasse 8
8274 Tägerwilen
Switzerland
Tel.: +41 (0)71 677 45 45
Fax: +41 (0)71 677 45 05

www.storzmedical.com
Personal data
Address
Contact data
Message